Explore

Trendline Trendline
GSK's Bepirovirsen Shows Promising Cure Rates for Chronic Hepatitis B

GSK's Bepirovirsen Shows Promising Cure Rates for Chronic Hepatitis B

GSK's Bepirovirsen Shows Promising Cure Rates for Chronic Hepatitis B
AP News AP News
Experimental hepatitis B drug might offer 'functional cure' for a subset of patients

Experimental hepatitis B drug might offer 'functional cure' for a subset of patients

New research suggests a first-of-its-kind drug for hepatitis B may let some patients stop treatment without showing signs of the dangerous liver virus
Trendline Trendline
Nielsen BioSciences Completes Successful Phase 3 Trial for CANDIN in Wart Treatment

Nielsen BioSciences Completes Successful Phase 3 Trial for CANDIN in Wart Treatment

Nielsen BioSciences Completes Successful Phase 3 Trial for CANDIN in Wart Treatment
Trendline Trendline
Precision BioSciences Reports Breakthrough in Hepatitis B Treatment with PBGENE-HBV

Precision BioSciences Reports Breakthrough in Hepatitis B Treatment with PBGENE-HBV

Precision BioSciences Reports Breakthrough in Hepatitis B Treatment with PBGENE-HBV
Trendline Trendline
Nielsen BioSciences Reports Successful Phase 3 Trial of CANDIN for Wart Treatment

Nielsen BioSciences Reports Successful Phase 3 Trial of CANDIN for Wart Treatment

Nielsen BioSciences Reports Successful Phase 3 Trial of CANDIN for Wart Treatment
Trendline Trendline
PharmaEssentia Appoints Eric Vogel as U.S. Head of Commercialization for BESREMi Expansion

PharmaEssentia Appoints Eric Vogel as U.S. Head of Commercialization for BESREMi Expansion

PharmaEssentia Appoints Eric Vogel as U.S. Head of Commercialization for BESREMi Expansion
Trendline Trendline
Veradermics to Present Phase 2/3 Study Results of VDPHL01 for Pattern Hair Loss at World Congress

Veradermics to Present Phase 2/3 Study Results of VDPHL01 for Pattern Hair Loss at World Congress

Veradermics to Present Phase 2/3 Study Results of VDPHL01 for Pattern Hair Loss at World Congress
Trendline Trendline
Brenus Pharma's STC-1010 Receives FDA IND Approval for Colorectal Cancer

Brenus Pharma's STC-1010 Receives FDA IND Approval for Colorectal Cancer

Brenus Pharma's STC-1010 Receives FDA IND Approval for Colorectal Cancer
Trendline Trendline
Brenus Pharma's Immunotherapy for Colorectal Cancer Receives FDA IND Approval

Brenus Pharma's Immunotherapy for Colorectal Cancer Receives FDA IND Approval

Brenus Pharma's Immunotherapy for Colorectal Cancer Receives FDA IND Approval
Trendline Trendline
MedTherapy Expands CAR-T Manufacturing in India to Reduce Costs and Increase Accessibility

MedTherapy Expands CAR-T Manufacturing in India to Reduce Costs and Increase Accessibility

MedTherapy Expands CAR-T Manufacturing in India to Reduce Costs and Increase Accessibility
Trendline Trendline
Merz Therapeutics and Kvvit Partner to Expand Parkinson's Treatment in Greater China

Merz Therapeutics and Kvvit Partner to Expand Parkinson's Treatment in Greater China

Merz Therapeutics and Kvvit Partner to Expand Parkinson's Treatment in Greater China
Trendline Trendline
Compass Pathways to Present at Jefferies Global Healthcare Conference

Compass Pathways to Present at Jefferies Global Healthcare Conference

Compass Pathways to Present at Jefferies Global Healthcare Conference